About ramipril
NHS medicines information on ramipril – what it's used for and key facts.
www.nhs.ukHere are the latest publicly available updates on ramipril I could verify recently:
Recall activity and safety alerts have occurred for ramipril in various regions due to manufacturing or packaging concerns. For example, England’s MHRA and UK NHS channels have reported class recalls and safety alerts affecting certain ramipril batches, with details like batch numbers and expiry dates highlighted for urgent checking by pharmacies and hospitals. This indicates ongoing post-market safety surveillance and batch-specific actions rather than a broad nationwide withdrawal.[3][4][5]
There continues to be active research and clinical discussions around ramipril’s role beyond hypertension, including its investigation in other conditions (e.g., historical explorations of ramipril in Covid-19 contexts). Such articles reflect both its established cardiovascular indications and the broader interest in RAAS-modulating therapies in acute illnesses.[2][7]
General prescribing information and patient-facing resources emphasize ramipril’s approved uses (hypertension, heart failure reduction, post-MMI risk reduction) and typical monitoring needs (blood pressure, kidney function, electrolytes). These NHS and pharmacy sources remain current for patients and providers seeking practical guidance.[8][9][10]
What this means for you:
If you’re taking ramipril, check with your pharmacist or prescriber about whether your lot is affected by any recalls or safety notices. They can verify batch numbers and advise on next steps if you have a recalled pack or if you notice any unusual symptoms.
For ongoing or new information, authoritative sources include national health service and regulatory agency updates in your country, as well as product recall notices from manufacturers. I can pull specific recall batch numbers and expiry dates if you tell me your country and the exact ramipril product you’re using (brand, dosage, and lot).
Would you like me to fetch the most current recall notices for your location and provider-usable guidance, or summarize the typical monitoring steps while on ramipril? I can also help you interpret any notices you’ve received.[4][9][8]
NHS medicines information on ramipril – what it's used for and key facts.
www.nhs.ukRamipril is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and prevent heart failure progression in patients with a history of myocardial infarction. This medication is also indicated for reducing the risk of myocardial infarction, stroke, and mortality in patients older than 55 who are at high risk for atherosclerotic disease and severe adverse cardiac events. Ramipril suppresses angiotensin II synthesis, reducing sympathetic activity and sodium and water...
www.ncbi.nlm.nih.govBatch affected GR174091
cpsc.org.ukOne batch of Ramipril 5 mg Capsules is being recalled as a precaution. Batch number: GR164099 Expiry date: 10/2026 Some cartons may contain Amlodipine 5 mg Tablets instead of Ramipril capsules due to a packaging error. … This is a Class 2 medicines recall, which means the issue could cause temporary or medically reversible health problems. What we are doing: Hospital wards supplied with this batch have been contacted and asked to check their stock. Any affected packs have been quarantined and...
swlstg.nhs.ukThe Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for ramipril 5mg capsules. Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site. Crescent Pharma Limited has received one complaint to date, where it has been identified that a pack of ramipril 5 mg Capsules (Batch Number GR164099) contains blister strips of Amlodipine 5 mg Tablets inside the...
www.rpharms.comNHS medicines information on common questions about ramipril.
www.nhs.ukResearchers from UC San Diego School of Medicine have initiated a clinical trial to study hypertension drug Ramipril as a potential Covid-19 treatment.
www.clinicaltrialsarena.com